Hypera SA
BOVESPA:HYPE3
Hypera SA
BOVESPA:HYPE3
Price:
22.1
BRL
0.45%
Market Cap:
R$15.6B
Relative Value
The Relative Value of one
HYPE3
stock under the Base Case scenario is
hidden
BRL.
Compared to the current market price of 22.1 BRL,
Hypera SA
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
HYPE3 Relative Value
HIDDEN
Multiples Across Competitors
HYPE3 Competitors Multiples
Hypera SA Competitors
Hypera SA Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| BR |
|
Hypera SA
BOVESPA:HYPE3
|
14.2B BRL | 2 | 17 | 13.5 | 17.1 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
863.3B USD | 13.3 | 42 | 28.4 | 30.3 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
571.4B USD | 6.1 | 21.3 | 14.8 | 18.2 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
257.8B CHF | 4.2 | 20 | 11.8 | 13.3 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
220.3B GBP | 5 | 28.9 | 16 | 22.6 | |
| CH |
|
Novartis AG
SIX:NOVN
|
228.9B CHF | 5.2 | 21.1 | 13.1 | 16.8 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
283.6B USD | 4.4 | 15.5 | 9.6 | 11.7 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
240.1B USD | 103.6 | -82.1 | 380.1 | 953.2 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.5 | 10.5 | 7.8 | 9.1 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
155.1B USD | 2.5 | 20 | 7.7 | 10.2 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
119.3B USD | 2.5 | 17 | 7.1 | 8.8 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
